As of 2025-07-01, the Relative Valuation of Stoke Therapeutics Inc (STOK) is 25.73 USD. This relative valuation is based on P/E multiples. With the latest stock price at 11.35 USD, the upside of Stoke Therapeutics Inc based on Relative Valuation is 126.7%.
The range of the Relative Valuation is 18.62 - 36.31 USD.
| Range | Selected | |
| Trailing P/E multiples | 20.2x - 28.0x | 25.3x |
| Forward P/E multiples | 23.6x - 39.4x | 30.6x |
| Fair Price | 18.62 - 36.31 | 25.73 |
| Upside | 64.0% - 219.9% | 126.7% |
| Date | P/E |
| 2025-06-30 | 12.33 |
| 2025-06-27 | 12.63 |
| 2025-06-26 | 12.86 |
| 2025-06-25 | 12.83 |
| 2025-06-24 | 12.50 |
| 2025-06-23 | 12.59 |
| 2025-06-20 | 12.58 |
| 2025-06-18 | 12.57 |
| 2025-06-17 | 12.66 |
| 2025-06-16 | 12.71 |
| 2025-06-13 | 12.52 |
| 2025-06-12 | 12.84 |
| 2025-06-11 | 12.49 |
| 2025-06-10 | 12.34 |
| 2025-06-09 | 12.09 |
| 2025-06-06 | 12.10 |
| 2025-06-05 | 11.82 |
| 2025-06-04 | 11.88 |
| 2025-06-03 | 11.84 |
| 2025-06-02 | 10.76 |
| 2025-05-30 | 10.36 |
| 2025-05-29 | 10.57 |
| 2025-05-28 | 10.24 |
| 2025-05-27 | 9.97 |
| 2025-05-23 | 10.17 |
| 2025-05-22 | 10.32 |
| 2025-05-21 | 10.30 |
| 2025-05-20 | 10.92 |
| 2025-05-19 | 10.68 |
| 2025-05-16 | 10.60 |
| 2025-05-15 | 10.46 |
| 2025-05-14 | 9.76 |
| 2025-05-13 | 9.70 |
| 2025-05-12 | 10.49 |
| 2025-05-09 | 10.17 |
| 2025-05-08 | 9.83 |
| 2025-05-07 | 9.41 |
| 2025-05-06 | 9.50 |
| 2025-05-05 | 10.54 |
| 2025-05-02 | 10.46 |
| 2025-05-01 | 10.72 |
| 2025-04-30 | 10.60 |
| 2025-04-29 | 10.33 |
| 2025-04-28 | 10.29 |
| 2025-04-25 | 10.60 |
| 2025-04-24 | 10.73 |
| 2025-04-23 | 10.34 |
| 2025-04-22 | 10.01 |
| 2025-04-21 | 9.35 |
| 2025-04-17 | 8.35 |